Rectal Carcinoma — Trials

Rectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

332 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 52
Ph III recruiting: 6
Growth YoY: −8%
Industry share: 2%
Top sponsor: City of Hope Medical Center
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 51–58 of 58 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00052559	Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer	completed	Phase 1	32	National Cancer Institute (NCI)NIH	1	Jun 5, 2013	clinicaltrials
NCT00002796	Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer	terminated	Phase 1 / Phase 2	46	National Cancer Institute (NCI)NIH	1	Feb 1, 2013	clinicaltrials